CANVITA Prenatal and Postpartum Multivitamins
Natural health product licensed in Canada
If this product were sold in France
- Dose déclarée au-delà d'une limite
Fer: up to 27 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine | 1.4 mg | 1,400 µg |
| Sélénium Source : Sélénate de sodium | 30 mcg | 30 µg |
| Fer Source : Citrate de fer (II) | 27 mg | 27,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 1.9 mg | 1,900 µg |
| Bêta-carotène Source : bêta-carotène | 2,500 UI | Not calculated |
| Bêta-carotène Source : bêta-carotène | 1,500 mcg | Not calculated |
| Calcium Source : Carbonate de calcium | 250 mg | 250,000 µg |
| Magnésium Source : Oxyde de magnésium | 50 mg | 50,000 µg |
Non-medicinal ingredients
Cellulose microcristalline, Croscarmellose de sodium, Dioxyde de silicium, Stéarate de magnésium, Poly(dextrose), Poly(éthylène glycol), Talc, Dioxyde de titane, Rouge FD&C N° 40, Laque d'aluminium FD&C Rouge n° 40, Poly(alcool vinylique), Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Antioxidant for good health. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps in energy metabolism and in tissue formation. Helps in the absorption (and use) of calcium and phosphorus. Helps in the development and maintenance of bones, cartilage, teeth and/or gums and in connective tissue formation. Helps in the development and maintenance of bones and teeth (especially in children and young adults). Helps normal growth and development. Helps pregnant women meet (the) (Health Canada's) recommended intake for iron, when taken in conjunction with a healthy diet. Helps to maintain eyesight/skin/membranes/(and) immune function (health). Helps to maintain eyesight and in the development and maintenance of night vision. Helps to maintain healthy bones, hair, nail and/or skin. Helps to maintain normal blood glucose levels. Helps to maintain normal function of the thyroid gland. Helps to maintain normal iron transport in the body. Helps to maintain normal metabolism of iron. Helps to maintain normal red blood cells. Helps to maintain proper muscle function, including the heart muscle. Helps to maintain the body's ability to metabolize nutrients. Helps to reduce the risk of neural tube defects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Helps to support normal early fetal development (brain and spinal cord). Provides/Source of/An electrolyte (for the maintenance of good health).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- Health One Prenatal and Postpartum Multivitamins
- Licence holder
- CANVITA CANADA LTD.
- NPN or DIN-HM
- 80107834
- Status
- Active licence
- Licence date
- 3 February 2021
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80107834
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “CANVITA Prenatal and Postpartum Multivitamins (CANVITA CANADA LTD.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80107834-canvita-prenatal-and-postpartum-multivitamins, updated 3 February 2021.